Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
Germany · Delayed Price · Currency is EUR 0.9650
+0.0050 (0.52%)
Aug 5, 2026, 5:35 PM CET
ETR:MAK Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 20 | 21 | 29 | 60 | 35 | 102 | |
Market Cap Growth | -26.34% | -25.00% | -52.45% | 71.26% | -65.64% | 10.96% |
Enterprise Value | 133.48 | 219.63 | 210.01 | 241.87 | 196.13 | 257.77 |
Last Close Price | 0.97 | 1.02 | 1.36 | 2.86 | 1.67 | 4.86 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 37.35 | 37.35 | 37.35 | 37.35 | 37.35 |
PS Ratio | 0.17 | 0.17 | 0.23 | 0.52 | 0.31 | 0.85 |
PB Ratio | -0.26 | -0.27 | -0.43 | -1.12 | -0.89 | -4.02 |
P/FCF Ratio | 1.81 | 1.92 | 2.06 | - | 15.00 | 6.65 |
P/OCF Ratio | 1.44 | 1.52 | 1.89 | 23.76 | 8.09 | 5.91 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 1.13 | 1.75 | 1.70 | 2.10 | 1.72 | 2.15 |
EV/EBITDA Ratio | 0.50 | 0.83 | 0.80 | 54.33 | 117.87 | 17.32 |
EV/EBIT Ratio | 0.52 | 0.86 | 0.84 | - | - | 68.50 |
EV/FCF Ratio | 11.96 | 19.68 | 15.16 | - | 84.03 | 16.81 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | -2.59 | -2.59 | -2.87 | -3.60 | -4.54 | -7.57 |
Debt / EBITDA Ratio | 0.78 | 0.78 | 0.72 | 42.11 | 102.35 | 11.36 |
Debt / FCF Ratio | 18.39 | 18.39 | 13.53 | - | 72.97 | 11.02 |
Net Debt / Equity Ratio | -2.44 | -2.44 | -2.69 | -3.35 | -4.05 | -5.99 |
Net Debt / EBITDA Ratio | 0.74 | 0.74 | 0.69 | 40.49 | 95.77 | 10.21 |
Net Debt / FCF Ratio | 17.63 | 17.63 | 12.98 | -125.18 | 68.28 | 9.90 |
Asset Turnover | 0.87 | 0.87 | 0.84 | 0.75 | 0.72 | 0.70 |
Inventory Turnover | -232.83 | -232.83 | -180.16 | 154.27 | 152.48 | 158.65 |
Quick Ratio | 0.20 | 0.20 | 0.12 | 0.29 | 0.29 | 0.47 |
Current Ratio | 0.21 | 0.21 | 0.13 | 0.30 | 0.30 | 0.48 |
Return on Equity (ROE) | 19.19% | 19.19% | 22.42% | 31.80% | 47.81% | 12.79% |
Return on Assets (ROA) | 191.95% | 191.95% | 216.89% | -3.90% | -5.29% | 1.63% |
Return on Invested Capital (ROIC) | 498.00% | 884.24% | 759.78% | -6.89% | -7.84% | 2.21% |
Return on Capital Employed (ROCE) | 814.34% | 814.34% | 593.35% | -6.08% | -8.69% | 2.96% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 5, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
FCF Yield | 55.16% | 52.18% | 48.59% | - | 6.66% | 15.05% |